Journal article
Randomized phase III U.S./Canadian intergroup trial (SWOG S9704) comparing CHOP ± R for eight cycles to CHOP ± R for six cycles followed by autotransplant for patients with high-intermediate (H-Int) or high IPI grade diffuse aggressive non-Hodgkin lymphoma (NHL).
Authors
Stiff PJ; Unger JM; Cook J; Constine LS; Couban S; Shea TC; Winter JN; Miller TP; Tubbs RR; Marcellus DC
Journal
Journal of Clinical Oncology, Vol. 29, No. 15_suppl, pp. 8001–8001
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2011
DOI
10.1200/jco.2011.29.15_suppl.8001
ISSN
0732-183X